Enlivex Therapeutics is blending biotech with blockchain. The clinical-stage company is deploying funds from its $212 million PE deal to build a crypto treasury
Related Posts
Calastone brings tokenized fund distribution to 4,500 institutions via Polygon
Calastone has integrated with proof-of-stake blockchain platform Polygon to tap into institutional-scale funds distribution for institutions across 58…
Intel Markets presale heats up with support from big-time SOL, TON holders
Excitement builds around the Intel Markets presale, drawing attention from major holders of Solana and Toncoin as they…
Interview | Big tech is training AI on junk data: Intuition
AI models are getting more powerful, but the data they’re trained on is getting worse, says Intuition founder…